Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Identifying Modulators of CXC Receptors 3 and 4 with Tailored Selectivity using Multi-Target Docking.
Genetic associations with brain cortical thickness in multiple sclerosis.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Vitamin D as a clinical biomarker in multiple sclerosis.
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System.
Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair.
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis.
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Vital role of specialist MS nurses recognised in proposed guideline.
Few patients with neurodegenerative disorders require spinal surgery.
The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Recent achievements in stem cell-mediated myelin repair.
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
[Multiple sclerosis and peripheral neuropathy].
IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
Pages
« first
‹ previous
…
385
386
387
388
389
390
391
392
393
…
next ›
last »